Trial NCT03625687

View at ClinicalTrials.gov 
Org. Study IDs: 2018P001697

Last trial update was posted on 2023-04-25

MeSH Interventions

Antiviral Agents Sofosbuvir-velpatasvir drug combination

MeSH Conditions

Hepatitis Hepatitis C Respiratory Insufficiency

Other Conditions

Respiratory Failure

Stopping Reasons

Lack of funding, transitioned to standard of care

Limitations And Caveats

Study was terminated prior to completion and prior to meeting enrollment goal primarily due to lack of resources (staffing and funding) and transition of HCV-positive to HCV-negative lung transplants to standard of care. Full planned analysis was not completed due to enrollment number, however primary endpoint was assessed for all 16 subjects receiving treatment.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID